Circulation-Cardiovascular Quality and Outcomes, published by LIPPINCOTT WILLIAMS & WILKINS, stands as a leading journal in the field of cardiology and cardiovascular medicine, boasting an impressive impact factor and ranking in the Q1 category for both Cardiology and Cardiovascular Medicine, as well as in the broader field of Medicine (miscellaneous) as of 2023. With a dedicated focus on enhancing cardiovascular health through high-quality research, this journal disseminates vital findings that address clinical practice, healthcare delivery, and policy improvements. Operating under a rigorous peer-review process, it offers a platform for innovative studies and evidence-based insights essential for researchers, healthcare professionals, and students committed to advancing cardiovascular care. Although not an open-access journal, its contributions are invaluable to the ongoing dialogue within the medical community, driving essential changes and advancements in cardiovascular outcomes.

Journal of Geriatric Oncology, published by Elsevier, stands at the intersection of geriatric medicine and oncology, addressing the unique needs and challenges of cancer management in older adults. Since its inception in 2010, this esteemed journal has played a pivotal role in advancing research and clinical practices, aiming to improve the quality of life and treatment outcomes for elderly cancer patients. With its impressive categorization in the 2023 Q2 quartile for both Geriatrics and Gerontology and Oncology, the journal demonstrates a noteworthy impact within its fields, ranking #153 out of 404 in Medicine – Oncology and #45 out of 116 in Medicine – Geriatrics and Gerontology. Researchers and healthcare professionals are encouraged to access critical insights through its rigorous peer-reviewed articles, which offer cutting-edge research findings and clinical applications. As the field continues to evolve, the Journal of Geriatric Oncology remains a vital resource for those dedicated to fostering innovation in geriatric oncology.

CA: A Cancer Journal for Clinicians is a prestigious academic journal published by Wiley, serving as a leading source of evidence-based information for those in the fields of oncology and hematology. With an impressive impact factor and ranked in the top quartile (Q1) for both specialties, this journal aims to bridge the gap between the latest research findings and clinical practice. Established in 1950, it boasts a long-standing history of delivering essential insights, guidelines, and innovative strategies to healthcare professionals worldwide, making significant contributions to the understanding and treatment of cancer. Although it does not offer open access, its published content is crucial for researchers, clinicians, and students dedicated to advancing cancer care. The journal's commitment to excellence is reflected in its elite rankings, holding the #1 position in both the Medicine – Oncology and Medicine – Hematology categories according to Scopus, positioning it in the 99th percentile of scholarly impact.

JAMA Surgery, an esteemed journal published by the American Medical Association, stands at the forefront of surgical research and innovation. With an impressive Impact Factor, it is ranked in the Q1 quartile in the field of Surgery, reflecting its pivotal role in advancing surgical knowledge and practices. The journal's robust reputation is further evidenced by its Scopus ranking as the top publication in the category of Medicine and Surgery, occupying the 1st position among 551 titles and placing in the 99th percentile overall. Covering a wide array of topics in surgery from 2013 to 2024, it serves as a critical resource for practitioners, researchers, and students alike, providing access to cutting-edge studies and insights. The journal also embraces an Open Access model, ensuring that high-quality surgical research is readily available to a global audience, thereby fostering collaboration and discovery in the medical community. Located in the heart of Chicago, a hub for medical research, JAMA Surgery continues to be an essential platform for disseminating impactful surgical findings that influence both clinical practice and health outcomes.

JNCI-Journal of the National Cancer Institute, published by Oxford University Press Inc. in the United Kingdom, is a premier journal dedicated to advancing the field of cancer research and oncology. With a distinguished history dating back to 1940, this journal has consistently maintained a strong reputation within the academic community, achieving a remarkable Q1 ranking in both Cancer Research and Oncology as of 2023. Researchers and practitioners rely on the JNCI for original research articles, review papers, and cutting-edge findings that impact clinical practices and therapeutic strategies. Although it does not currently offer open access, the journal remains a vital resource for academicians and healthcare professionals seeking to enhance their understanding of cancer mechanisms and treatment innovations. Its rigorous peer-review process ensures the publication of high-quality, credible research that meets the evolving challenges of cancer treatment and prevention through to 2024.

Oncology Letters is a prominent academic journal dedicated to disseminating high-quality research in the fields of oncology and cancer research. Published by SPANDIDOS PUBL LTD and based in Greece, this journal has established a significant presence since its inception in 2010 and continues to contribute to the scientific community with a focus on both clinical and experimental oncology. Notably, it holds a respectable Q3 ranking in the categories of Cancer Research and Oncology as of 2023, highlighting its relevance and contribution to these critical fields. With a Scopus rank of #139/404 in Medicine – Oncology and #117/230 in Biochemistry, Genetics, and Molecular Biology – Cancer Research, Oncology Letters serves as a valuable platform for researchers, professionals, and students alike to explore emerging findings and innovative treatment approaches. Though it operates within a traditional subscription model, this journal prides itself on fostering accessible and impactful discourse in oncology, making it an essential resource for those committed to advancing cancer research and improving patient care.

Asia-Pacific Journal of Clinical Oncology is an essential publication within the field of medical oncology, dedicated to advancing the understanding and treatment of cancer through rigorous research and innovative clinical practices. Published by WILEY, this journal has established itself as a significant resource for researchers, healthcare professionals, and students interested in the latest findings across the Asia-Pacific region and beyond. With a respectable impact factor and categorized within the Q2 and Q3 quartiles of Medicine (miscellaneous) and Oncology respectively, the journal aims to disseminate knowledge on diverse aspects of clinical oncology, promoting the improvement of patient care and treatment outcomes. The Asia-Pacific Journal of Clinical Oncology, operating from the United Kingdom, invites contributions that highlight significant findings and advancements in oncology, making it a crucial platform for collaboration and knowledge sharing in this vital field of medicine.

JCO Global Oncology is a premier open-access journal published by Lippincott Williams & Wilkins, dedicated to the dissemination of high-quality research in the fields of cancer research and oncology. Since its inception in 2020, this journal has rapidly established itself as a vital resource for researchers, healthcare professionals, and students, holding a distinguished position in the Q2 category for both Cancer Research and Oncology based on the latest metrics. With an impressive Scopus rank of #61 out of 636 in General Medicine, the journal is recognized for its rigorous peer-reviewed articles and cutting-edge insights into oncological science. The open-access model ensures that vital research is readily available to a global audience, fostering collaborative advancements in the fight against cancer. JCO Global Oncology explores a broad range of topics and encourages submissions that contribute to the understanding, prevention, and treatment of various malignancies. With its substantial impact and ongoing contributions to the field, it stands as a promising platform for advancing oncological discourse and knowledge.

JNCI Cancer Spectrum, published by Oxford University Press, is a leading open-access journal dedicated to advancing the field of cancer research and oncology. With an impressive impact demonstrated through its Q1 ranking in both Cancer Research and Oncology categories for 2023, this journal provides a vital platform for disseminating high-quality research and innovative findings in a rapidly evolving landscape. Since its inception in 2017, JNCI Cancer Spectrum has embraced open access, enhancing the accessibility of evidence-based knowledge to researchers, professionals, and students across the globe. Additionally, it boasts notable positions in Scopus rankings, with a strong performance in both the Medicine and Biochemistry, Genetics and Molecular Biology categories. The journal is committed to its objectives of fostering collaborative efforts and encouraging dialogue among experts, making it an essential resource for anyone involved in cancer research.

BREAST is a leading peer-reviewed journal dedicated to advancing knowledge and practice in the fields of cancer research, oncology, and surgery, published by Churchill Livingstone. With an impressive impact factor and a prestigious Q1 ranking in multiple categories including Cancer Research, Medicine, and Surgery, the journal consistently delivers high-quality content that informs and inspires researchers, clinicians, and educators. Since its transition to Open Access in 2020, BREAST has significantly expanded its reach, providing immediate and unrestricted access to pivotal studies and findings in breast health and disease management. With a history dating back to 1992 and converging to 2024, the journal serves as an essential resource for the latest developments and innovative approaches in the clinical and biomedical aspects of breast care. Scholars and professionals alike can explore a wealth of research aimed at improving patient outcomes and fostering scientific dialogue in this vital area of healthcare.